BFM 89.9

HIGHLIGHTS 
Podcast  >  Morning Run  >  The Breakfast Grille  >  From Startup To IPO, Aemulus Tells Their Story

From Startup To IPO, Aemulus Tells Their Story

02-Sep-15 08:07

From Startup To IPO, Aemulus Tells Their Story

Aemulus Holdings Berhad is a tech startup that went from being a company solely funded by founders, to being a publicly listed company on the stock exchange. Backed by popular VC firm, Teak Capital, Aemulus is in the technology sector, and has large MNC chip maker clients. Listen to this grille where we ask CEO, Ng Sang Beng, on whether this is the right time to list, and also what their expectations are with regards to utilizing the proceeds they receive from this listing exercise.


This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.

Categories: 

Tags:  breakfast grille





Play / Pause

Listen now : BFM 89.9 -- The Business Station

Today’s Shows



6:00 AM

The 6AM Stretch

7:00 AM

World Market Watch

Tony Nash, CEO, Complete Intelligence

7:15 AM

Morning Brief

7:30 AM

Morning Brief

Adrian Chew, ASEAN AI and Data Leader, EY

7:45 AM

Morning Brief

Ahmad Maghfur Usman, Equity Analyst, Nomura Malaysia

8:00 AM

The Breakfast Grille

Manu Bhaskaran, Founding Partner & President, Centennial Asia Advisors

8:30 AM

Morning Brief

Dr. Rachel Gong, Deputy Director, Khazanah Research Institute

8:45 AM

Morning Brief

Dr Syaza Shukri, Associate Professor, International Islamic University of Malaysia (IIUM)

9:00 AM

Opening Bell

9:15 AM

Opening Bell

9:35 AM

What's the Focus

10:05 AM

Open For Business

Isaac Kon, CEO and Founder, Heytech Sdn Bhd

11:05 AM

Resource Centre

Matt Armitage, Founder, Kulturpop

12:00 PM

Enterprise Explores

Michael Freese, Professor of Management, Asia School of Business

1:00 PM

The Breakfast Grille Repeat

Manu Bhaskaran, Founding Partner & President, Centennial Asia Advisors

2:05 PM

Front Row

tbc

2:20 PM

Front Row

tbc

3:05 PM

Good Things

Native Allies; Daniel Teoh, Founder, Native

4:05 PM

Health & Living

Why A New TB Vaccine Is An Investment Worth Making; Dr Allison Portnoy, Assistant Professor of Global Health, Boston University School of Public Health

5:00 PM

The Evening Edition

7:05 PM

The Evening Edition

7:30 PM

Just For Kicks

9:00 PM

A Bit of Culture